Cargando…

Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study

Objective To evaluate the cumulative incidence of cervical intraepithelial neoplasia II or worse (grade II+) or cervical intraepithelial neoplasia grade III+ after short term persistence of prevalently detected carcinogenic human papillomavirus (HPV). Design Population based cohort study. Setting Gu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castle, Philip E, Rodríguez, Ana Cecilia, Burk, Robert D, Herrero, Rolando, Wacholder, Sholom, Alfaro, Mario, Morales, Jorge, Guillen, Diego, Sherman, Mark E, Solomon, Diane, Schiffman, Mark
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2718087/ https://www.ncbi.nlm.nih.gov/pubmed/19638649 http://dx.doi.org/10.1136/bmj.b2569

Ejemplares similares

Single Nucleotide Polymorphisms in the PRDX3 and RPS19 and Risk of HPV Persistence and Cervical Precancer/Cancer
por: Safaeian, Mahboobeh, et al.
Publicado: (2012)

A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection
por: Clarke, Megan A, et al.
Publicado: (2012)

Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer
por: Wang, Sophia S., et al.
Publicado: (2010)

Genetic and Epigenetic Variations of HPV52 in Cervical Precancer
por: Bee, Katharine J., et al.
Publicado: (2021)

Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials
por: Wacholder, Sholom, et al.
Publicado: (2010)

Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment
por: Hildesheim, Allan, et al.
Publicado: (2016)

A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica
por: Clarke, Megan, et al.
Publicado: (2013)

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial
por: Panagiotou, Orestis A, et al.
Publicado: (2015)

Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica
por: Wang, S S, et al.
Publicado: (2004)

A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria
por: Clarke, Megan A, et al.
Publicado: (2011)

Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy
por: Demarco, Maria, et al.
Publicado: (2018)

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
por: Kreimer, Aimée R., et al.
Publicado: (2011)

Comparison of Antibody Responses to Human Papillomavirus Vaccination as Measured by Three Assays
por: Robbins, Hilary A., et al.
Publicado: (2014)

Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
por: Herrero, Rolando, et al.
Publicado: (2013)

Sequence Imputation of HPV16 Genomes for Genetic Association Studies
por: Smith, Benjamin, et al.
Publicado: (2011)

Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer
por: Mukherjee, Amrita, et al.
Publicado: (2023)

HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica
por: Hildesheim, A, et al.
Publicado: (2001)

Determinants of seropositivity among HPV-16/18 DNA positive young women
por: Porras, Carolina, et al.
Publicado: (2010)

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019)

Risk Factors for Cervical Precancer and Cancer in HIV-Infected, HPV-Positive Rwandan Women
por: Anastos, Kathryn, et al.
Publicado: (2010)

The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States
por: Wheeler, Cosette M, et al.
Publicado: (2014)

Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica
por: Wang, S S, et al.
Publicado: (2003)

The Cervical Microbiome over 7 Years and a Comparison of Methodologies for Its Characterization
por: Smith, Benjamin C., et al.
Publicado: (2012)

A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes
por: Brentnall, Adam R, et al.
Publicado: (2014)

Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan
por: Onuki, Mamiko, et al.
Publicado: (2020)

Intra-Patient Genomic Variations of Human Papillomavirus Type 31 in Cervical Cancer and Precancer
por: Kogure, Gota, et al.
Publicado: (2023)

Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus
por: Robbins, Hilary A, et al.
Publicado: (2014)

Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans
por: Chen, Zigui, et al.
Publicado: (2018)

Ensemble Deep Learning for Cervix Image Selection toward Improving Reliability in Automated Cervical Precancer Screening
por: Guo, Peng, et al.
Publicado: (2020)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

A mobile-phone based high-resolution microendoscope to image cervical precancer
por: Grant, Benjamin D., et al.
Publicado: (2019)

Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria
por: Musa, Jonah, et al.
Publicado: (2023)

T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study
por: Lang Kuhs, Krystle A., et al.
Publicado: (2018)

The economic burden of human papillomavirus-related precancers and cancers in Sweden
por: Östensson, Ellinor, et al.
Publicado: (2017)

Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity
por: Kudo, Risa, et al.
Publicado: (2022)

Thermocoagulation versus cryotherapy for the treatment of cervical precancers
por: Duan, Lyufang, et al.
Publicado: (2020)

Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination
por: Song, Fangbin, et al.
Publicado: (2022)

Correction: The economic burden of human papillomavirus-related precancers and cancers in Sweden
por: Östensson, Ellinor, et al.
Publicado: (2018)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

HPV testing of self-samples: Influence of collection and sample handling procedures on clinical accuracy to detect cervical precancer
por: Arbyn, Marc, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ek92c2mu0c98d8qejtefmtmo6f